PPMA is fearful that the Government of Pakistan’s recent call for more foreign investment in the local pharma sector will go unheard because the industry is already overcrowded.
Catalent and Bend Research have joined forces to tackle time and cost restrictions for the complex oral controlled-release development and manufacturing process.
Drug regulators and the biomanufacturing industry need to embrace drug delivery via the skin to solve solubility problems with peptides and proteins, according to Across Barriers’ Udo Bock.
Outsourcing-Pharma.com presents its latest round-up of the new appointments in the pharmaceutical industry, including news from Covance, NIH and EMD Serono.
Articles comparing CEO salaries are ten-a-penny at outsourcing publications these days as they use readily available data, are quick to compile and – to be frank – generate the strong web traffic that advertisers love.
Regulation of clinical trials in emerging markets is now too strict and is prompting sponsors and CROs to adopt “one-size-fits-all” designs, according to a new study.
SAFC has coupled its chiral screening and small-scale purification services to meet what it says is a boom in demand for more complete chemical analysis from drugmakers.
